Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Grifols

By abhat@reaganud… on Fri, 05/15/2020 - 09:38
  • Read more about Grifols

Innate Pharma, Inc.

By abhat@reaganud… on Fri, 05/15/2020 - 09:28
  • Read more about Innate Pharma, Inc.

Erytech

By efain on Wed, 05/13/2020 - 15:58
  • Read more about Erytech

Myeloproliferative Neoplasms (MPN) and COVID-19

  • Read more about Myeloproliferative Neoplasms (MPN) and COVID-19

Predictive Immune Biomarkers for COVID-19 Pathogenesis

  • Read more about Predictive Immune Biomarkers for COVID-19 Pathogenesis

HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital

  • Read more about HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital

Epirium Bio Inc

By efain on Tue, 05/12/2020 - 16:40
  • Read more about Epirium Bio Inc

Mendus

By efain on Tue, 05/12/2020 - 12:48
  • Read more about Mendus

MorphoSys

By efain on Tue, 05/12/2020 - 12:42
  • Read more about MorphoSys

Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)

  • Read more about Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 222
  • Page 223
  • Page 224
  • Page 225
  • Current page 226
  • Page 227
  • Page 228
  • Page 229
  • Page 230
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA